BalkoResearchLab
@BalkoLab
Followers
657
Following
773
Media
64
Statuses
615
We are the Balko Research Lab at VUMC, a translational cancer research lab at the interface of tumor biology and immunotherapy. Opinions RR own.
Nashville, TN
Joined February 2019
Looks amazing! Great work @ECBrunner!.
Check out this article that made the 2025 cover of Cancer Research Communications: . Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast Cancer @BalkoLab
0
0
0
RT @SABCSSanAntonio: State of the Art: The Winding Road of Immune Biomarkers in Early Breast Cancer—Roberto Salgado, Justin Balko, and Priy….
0
7
0
RT @SABCSSanAntonio: State of the Art: The Winding Road of Immune Biomarkers in Early Breast Cancer—.Roberto Salgado, Justin Balko, and Pri….
0
1
0
RT @HanZhuMD: Next, @MargaretAxelrod talks about patient and tumor specific biomarkers in ici myocarditis👌 #gcos #gcos24 @ICOSociety @Balko….
0
6
0
RT @AmirZMunir: As we better understand mechanisms that may drive ICI-myocarditis, we can think of more targeted therapies! Work by many in….
0
1
0
RT @DFCI_BreastOnc: #ASCO24 Poster Session | Analysis of the sensitivity to endocrine therapy assay in the PALLAS adjuvant trial of palboci….
0
2
0
RT @SusanGKomen: Komen grantee @BalkoLab presents his work on understanding and improving #breastcancer response to immunotherapy @ #AACR24….
0
3
0
So proud of this outstanding scientist and person @BCT255 defending her thesis today. A @SusanGKomen ASPIRE scholar, @CD_AACR @jitcancer published author and all around superstar. Can't wait to see what the future holds!! @VUMCResearch @VUBasicSciences
0
5
19
RT @BReinfeld: Great talk with wonderful implications for the next generation of myeloid therapy in ccRCC. Can’t w….
0
1
0
RT @CD_AACR: From the latest issue—.#NKG2A is a Therapeutic Vulnerability in #Immunotherapy Resistant MHC-I Heterogeneous Triple Negative #….
0
4
0
Super excited for next year's meeting! Only 290 days and counting (OK you got me. I didn't do the math I just guessed 😂).
We thank our program committee for creating a great #SABCS24 lineup. @VKaklamani @CarlosArteagaMD @BalkoLab @tperrybrown @heide_ford @HarrisLabUTHSA @TariKingMD @lab_kok @Adrianvlee @itsnot_pink @hmcarthur @dapattmd @c_sotiriou @atanmdlci @NeilVasan @adawaksmd @awolff @AACR_CEO
0
0
5
Excited to see the *official* version out!!! Great job by the editorial staff. It looks phenomenonal!.
From the February issue—.#NKG2A is a Therapeutic Vulnerability in #Immunotherapy Resistant MHC-I Heterogeneous Triple Negative #BreastCancer, by @BCT255, @SXPung, @BalkoLab et al. @VUMCDiscoveries #TNBC
0
1
15
RT @SusanGKomen: Tune in NOW for Breast Cancer Breakthroughs! Hear about the most exciting wins for patients announced at #SABCS23 from Kom….
0
1
0
RT @VUBasicSciences: A recent paper from the @balkolab, led by Jamaal James and @bct255, indicates that EZH2 inhibition leads to enhanced M….
0
2
0
RT @kahoadley: Congrats @paspears88 on such a well deserved award! 2023 Komen Research Advocacy Champion Award! @UNC_Lineberger #SABCS23 @….
0
9
0
